RecruitingNCT05202210

Constitution of a Biological Collection to Study the Pathophysiology in Noonan Syndrome

Constitution of a Biological Collection to Study the Pathophysiology in Noonan Syndrome and to Identify Predictive Factors of Disease Progression

Sponsor

University Hospital, Toulouse

Enrollment

100 participants

Start Date

Jan 26, 2022

Study Type

OBSERVATIONAL

Conditions

Noonan Syndrome

Summary

The present study will establish a collection of biological samples from Noonan patients to be used for research purposes only, with due respect for confidentiality.

Eligibility

Min Age: 18 YearsMax Age: 99 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a biological treatment called blood and urine sampling for people with noonan syndrome. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 99 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BIOLOGICALblood and urine sampling

extra sample of blood and urine will be collected

Locations(1)

Purpan University Hospital

Toulouse, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05202210

Related Trials

Clinical, Genetic, and Epidemiologic Study of Children and Adults With RASopathies

NCT048889362 locations

A Study of Vosoritide in Children With Noonan Syndrome With Inadequate Growth During or After Human Growth Hormone Treatment

NCT0666880536 locations

National Multicentre Study on Lipid Profile in Noonan Syndrome and Related Disorders: Trends by Age, Gender and Genotype

NCT0746482114 locations

Acceptance and Commitment Therapy for Caregivers of Children With a RASopathy: An Internal Pilot Feasibility Study and Follow-up Randomized Controlled Trial

NCT053618111 location

Precision Diagnosis and Risk Stratification of Rare Cardiomyopathies Based on Novel Cardiac Magnetic Resonance Techniques

NCT073363941 location